The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Compliance and arthralgias in clinical therapy (COMPACT): Assessment of the incidence of arthralgia, therapy costs, and compliance in the first year of adjuvant anastrozole.
Peyman Hadji
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Maria Blettner
Consultant or Advisory Role - AstraZeneca
Wolfgang W. Bolten
Consultant or Advisory Role - AstraZeneca
Honoraria - speeches
Nadia Harbeck
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Hans-Joachim Hindenburg
No relevant relationships to disclose
Christian Jackisch
Honoraria - AstraZeneca
Peter Klein
Other Remuneration - AstraZeneca
Klaus K├Ânig
No relevant relationships to disclose
Winfried Rief
Consultant or Advisory Role - AstraZeneca
Diethelm Wallwiener
No relevant relationships to disclose
Silke Zaun
Employment or Leadership Position - AstraZeneca
Rolf Kreienberg
Consultant or Advisory Role - AstraZeneca
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Novartis; Roche